Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
May 11th, 2008
Aida Pharmaceuticals, Inc. (BULLETIN BOARD: AIDA) announced that it has completed the acquisition of a controlling interest in Jiangsu Institute of Microbiology Co., Ltd. ("JSIM"), one of the leading microbiology research institutes in the People's Republic of China. JSIM has several drugs currently undergoing clinical testing and has new products in its development pipeline. This acquisition is expected to add several new products to Aida Pharmaceutical Inc.'s existing line of products, thus diversifying its product mix and enabling the Company to increase its market share in the PRC pharmaceutical market. The controlling interest in JSIM was acquired through two of...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-11)
|
